Vontobel Holding’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,000
Closed -$2.76K 1167
2024
Q1
$2.76K Hold
20,000
﹤0.01% 1084
2023
Q4
$2.91K Hold
20,000
﹤0.01% 1100
2023
Q3
$3.53K Hold
20,000
﹤0.01% 1065
2023
Q2
$62.4K Buy
+20,000
New +$59.5K ﹤0.01% 1067

Other funds holding GRTX

Vontobel Holding's GRTX Position: Q2 2024 in Review

Vontobel Holding sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 20,000 shares — an estimated $2.76K sold.

Vontobel Holding first reported a position in GRTX in Q2 2023 and held it in 4 quarters. The position peaked at $62.4K in Q2 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Vontobel Holding reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vontobel Holding sold 20,000 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $2.76K.
  • Vontobel Holding first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Vontobel Holding's Galera Therapeutics, Inc. Common Stock position peaked at $62.4K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.